You are using an older browser version. Please use a supported version for the best MSN experience.

FDA approves new drug to slow progress of ALS

The FDA approved a drug from Amylyx Pharmaceuticals designed to slow the progress of ALS. The drug’s approval marks a victory for patients and advocates, despite ongoing questions about its effectiveness.
image beaconimage beaconimage beacon